Lumber Liquidators last earnings report blew past expectations.
Generic drugmaker Mylan is a smart healthcare play
With the population aging, healthcare is a growth sector.
Lumber Liquidators is riding the housing revival
The housing recovery offers attractive opportunities for investors.
Here's why I dumped Ford and bought Colgate Palmolive
When it comes to stock picking, I stick with the winners and cut loose the losers.
Starbucks' double shot: It's both a US recovery and China play
Why I sold my Apple holdings and picked up Starbucks.
Healthcare poised for growth under Obamacare
Healthcare reform will bring more patients and boost profits.
We sold Microsoft and picked up Hologic in the portfolio
The Sustained Momentum model is performing well vs. the S&P 500 Index.
Reshuffling the lineup for my Healthcare portfolio
We did some housecleaning in the Health Care portfolio.
Why I sold Apple and bought Ecolab
Here's a breakdown of my portfolio changes in October.
Why the Obama way is good for the economy
Obama's policy agenda has a good shot of leading American back to prosperity.
